Aadi Bioscience Inc (AADI)
1.96
-0.03
(-1.51%)
USD |
NASDAQ |
Nov 04, 16:00
1.96
0.00 (0.00%)
After-Hours: 05:44
Aadi Bioscience Gross Profit Margin (Quarterly): 87.41% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 87.41% |
| March 31, 2024 | 87.82% |
| December 31, 2023 | 85.35% |
| September 30, 2023 | 88.30% |
| June 30, 2023 | 89.42% |
| Date | Value |
|---|---|
| March 31, 2023 | 90.98% |
| December 31, 2022 | 95.75% |
| September 30, 2022 | 86.03% |
| June 30, 2022 | 90.08% |
| March 31, 2022 | 92.24% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
85.35%
Minimum
Dec 2023
95.75%
Maximum
Dec 2022
89.34%
Average
88.86%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bio-Path Holdings Inc | -- |
| PROCEPT BioRobotics Corp | 63.24% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -62.44% |
| Return on Assets | -51.45% |
| Return on Invested Capital | -62.44% |
| Profit Margin (Quarterly) | -236.0% |
| Operating Margin (Quarterly) | -252.2% |
| Return on Net Operating Assets | -408.0% |